Breaking News Instant updates and real-time market news.

BABA

Alibaba

$187.11

0.5 (0.27%)

, FB

Facebook

$190.86

0.48 (0.25%)

20:02
11/10/19
11/10
20:02
11/10/19
20:02

Fly Intel: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Alibaba Group's (BABA) Singles' Day shopping holiday, 11/11, started off strong. In the first minute and eight seconds, gross merchandise volume, or GMV, settled through Alipay reached $1.0B. In the first hour, GMV settled through Alipay had reached $12.0B. 2. Facebook (FB) subsidiary Instagram's CEO Adam Mosseri said in a Wired interview that Instagram will start hiding likes on the platform for U.S. audiences beginning next week, saying the goal is to"depressurize Instagram, make it less of a competition." 3. New York's Department of Financial Services is opening a probe into Goldman Sachs' (GS) credit card practices after a tech entrepreneur's viral tweet "alleged gender discrimination in the new Apple (AAPL) Card's algorithms when determining credit limits," according to Bloomberg. "The department will be conducting an investigation to determine whether New York law was violated and ensure all consumers are treated equally regardless of sex. Any algorithm, that intentionally or not results in discriminatory treatment of women or any other protected class of people violates New York law." 4. Lionsgate's (LGF.A, LGF.B) World War II film "Midway," directed by Roland Emmerich, was predicted to finish in fourth place this weekend, with a projected gross of around $13M. However, a combination of "Midway" overperforming, with an estimated weekend gross of $17.5M, and both AT&T (T) subsidiary Warner Bros. horror film "Doctor Sleep" and Comcast (CMCSA, CMCSK) subsidiary Universal Pictures' romantic comedy "Last Christmas" underperforming, gave the top spot to the World War II drama. 5. Honeywell (HON) and Oshkosh (OSK) both got positive mentions in this week's edition of Barron's, while Uber (UBER) received a negative mention.

BABA

Alibaba

$187.11

0.5 (0.27%)

FB

Facebook

$190.86

0.48 (0.25%)

GS

Goldman Sachs

$222.92

-0.21 (-0.09%)

AAPL

Apple

$260.20

0.78 (0.30%)

LGF.A

Lionsgate

$9.11

0.79 (9.50%)

LGF.B

Lionsgate

$8.58

0.73 (9.30%)

T

AT&T

$39.37

-0.05 (-0.13%)

CMCSA

Comcast

$45.19

0.49 (1.10%)

CMCSK

Comcast

$0.00

(0.00%)

HON

Honeywell

$181.21

1.54 (0.86%)

OSK

Oshkosh

$90.00

1.19 (1.34%)

UBER

Uber

$27.01

-0.33 (-1.21%)

  • 11

    Nov

  • 12

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 29

    Jan

BABA Alibaba
$187.11

0.5 (0.27%)

11/01/19
RHCO
11/01/19
NO CHANGE
Target $212
RHCO
Buy
Alibaba continues to execute in 'challenging backdrop', says SunTrust
SunTrust analyst Youssef Squali nudged his price target on Alibaba higher to $212 from $210 and kept his Buy rating after its Q2 results, saying the company is executing "very well against a challenging macro backdrop" while also gaining market share. The analyst notes that the secular growth drivers for Alibaba, including rising China consumption and "digitization" of retail, are still in place, with added support from "healthy" household balance sheets. Squali believes that the company remains on track for "outsized" growth for years to come.
11/01/19
BARD
11/01/19
NO CHANGE
Target $200
BARD
Outperform
Baird remains a buyer of Alibaba after 'solid' Q2 report
Baird analyst Colin Sebastian said he remains a buyer of Alibaba shares following the company's "solid" fiscal second quarter results, which show that the company continues to execute well. He thinks that increasing traction in lower-tier cities, international markets, and local services can improve the company's competitive position and sees management's comments about "aggressive" spending being consistent with prior commentary. Sebastian raised his estimates and increased his price target for Alibaba to $200 from $195 and he maintains an Outperform rating on the stock.
11/04/19
STFL
11/04/19
NO CHANGE
Target $220
STFL
Buy
Stifel says Alibaba's more aggressive spending already priced in
Stifel analyst Scott Devitt said that comments made by Alibaba along with the company's fiscal second quarter report about aggressive spending in the back half of the fiscal year may cause concern for some investors, but he believes the more aggressive spending expectations are already largely priced into those consensus estimates. He added that the company reported a "solid" Q2 and he sees the company's investments in local services, international, logistics, and new retail strengthening the platform and expanding Alibaba's reach. Devitt keeps a Buy rating on Alibaba shares, but trimmed his price target for the stock to $220 from $225, primarily due to foreign exchange impacts.
10/23/19
VERF
10/23/19
INITIATION
VERF
Buy
Alibaba initiated with a Buy at Vertical Group
FB Facebook
$190.86

0.48 (0.25%)

11/05/19
11/05/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Facebook (FB) upgraded to Buy from Outperform at Daiwa with analyst Satoshi Tanaka saying the company's Q3 results and 2020 outlook last week go a "long way to alleviate concerns." 2. Beyond Meat (BYND) upgraded to Outperform from Market Perform at Bernstein with analyst Alexia Howard saying she is making a "straightforward valuation call" with the shares down 66% from their peak. 3. NXP Semiconductors (NXPI) upgraded to Buy from Neutral at Mizuho with analyst Vijay Rakesh saying the company's auto segment is showing signs of recovery, with easier compares and content wins. 4. Amgen (AMGN) upgraded to Overweight from Neutral at Cantor Fitzgerald with analyst Alethia Young saying recent events have set the stage for a "clean base business and pipeline story" for Amgen in 2020. 5. Autoliv (ALV) upgraded to Buy from Neutral at Mizuho with analyst Vijay Rakesh saying an improving 2020-2021 auto outlook with easier compares, continued airbag market share gains versus Takata, and lower product launch costs position Autoliv well. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/04/19
SPHN
11/04/19
INITIATION
Target $250
SPHN
Overweight
Stephens starts Trade Desk at Overweight, touts model compared to Netflix, Roku
Stephens analyst Kyle Evans initiated coverage of Trade Desk (TTD) with an Overweight rating and $250 price target, stating that he believes investors should own the stock because the company has "a more distributed, defendable and profitable business model" than Netflix (NFLX) or Roku (ROKU) with fewer regulatory risks than Google (GOOGL) or Facebook (FB), although he added that the stock is "volatile and expensive." He sees the catalysts of connected TV tailwinds and international growth outweighing the risks of a premium multiple and the growth of ad-free streaming TV options, Evans added.
11/04/19
DAIW
11/04/19
UPGRADE
DAIW
Buy
Facebook upgraded to Buy from Outperform at Daiwa
11/05/19
DAIW
11/05/19
UPGRADE
Target $250
DAIW
Buy
Daiwa upgrades Facebook to Buy, says earnings concerns 'largely alleviated'
Daiwa analyst Satoshi Tanaka last night upgraded Facebook to Buy from Outperform with a price target of $250, up from $235. The company's Q3 results and 2020 outlook last week go a "long way to alleviate concerns," Tanaka tells investors in a research note. The analyst sees "clearer visibility" from 2020 as well as higher upside after the stock's recent pullback. Facebook's revenue growth slowdown is more moderate than previously anticipated while its guidance for total expenses remains within expectations, contends the analyst. He believes the "negative repercussions" stemming from the implementation of Europe's new data protection regulation and Facebook's data leak "controversy are clearer now that a year has passed." Concerns on the earnings front "have largely been alleviated," says Tanaka.
GS Goldman Sachs
$222.92

-0.21 (-0.09%)

10/14/19
KBWI
10/14/19
NO CHANGE
KBWI
Hard for Goldman, Morgan Stanley to justify E-Trade deal, says Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl looked into whether an acquisition of E-Trade (ETFC) would make sense for Goldman Sachs (GS) or Morgan Stanley (MS) after the electronic brokers reduced their commission rates. The analyst says he could make the strategic rationale for why a broker would buy an e-broker, namely cost savings and customer base expansion. However, ultimately a deal has to make sense financially as well, and it would be hard for Morgan or Goldman to justify on this basis, Kleinhanzl tells investors in a research note. In addition, with both brokers trading near tangible book value, shareholders would prefer buybacks versus an acquisition as a better use of shareholder capital at this point in the cycle, adds the analyst. As such a result, Kleinhanzl sees a deal for E-Trade as unlikely given the financial and capital impacts. He would be surprised if either broker aggressively pursued E-Trade as an acquisition.
10/16/19
OPCO
10/16/19
NO CHANGE
Target $301
OPCO
Outperform
Goldman Sachs price target lowered to $301 from $316 at Oppenheimer
Oppenheimer analyst Chris Kotowski lowered his price target for Goldman Sachs to $301 from $316 following quarterly results. The analyst reiterates an Outperform rating on the shares.
10/16/19
BMOC
10/16/19
NO CHANGE
Target $278
BMOC
Market Perform
Goldman Sachs price target raised to $278 from $273 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Goldman Sachs to $278 after its Q3 earnings beat that was driven by higher than expected Institutional Client Services revenues coming from higher equities trading results and "notably lower" compensation expenses. Despite the 37% total return implied by his price target however, the analyst is keeping his Market Perform rating on the company, saying he prefers to remain on the sidelines until the conclusion of its "front-to-back" business line review expected in January of next year as well as the potential disclosure of its new efficiency and return targets.
10/02/19
ODEN
10/02/19
NO CHANGE
ODEN
Hold
Goldman Sachs 'quite likely' to beat Q3 earnings consensus, says Odeon Capital
Odeon Capital analyst Richard Bove pointed out three reasons that he believes it is "quite likely" that Goldman Sachs will top the Q3 consensus EPS forecast of $5.41. The bank was ranked by Bloomberg as number one in U.S. equity offerings in the quarter, trading activity is likely to be higher on both a sequential and year-over-year basis and Goldman "typically" starts the process of lowering estimated compensation expenses in Q3, said Bove. Bove keeps a Hold rating on Goldman Sachs shares, noting that he thinks Goldman is unlikely to match its Q3 results in Q4.
AAPL Apple
$260.20

0.78 (0.30%)

11/06/19
DADA
11/06/19
NO CHANGE
Target $20
DADA
Buy
Sonos rallies after DA Davidson calls 'natural acquisition target' for Apple
DA Davidson analyst Tom Forte reiterates a Buy rating on Sonos (SONO) with a $20 price target following Alphabet's (GOOG, GOOGL) acquisition of Fitbit (FIT). The stock in early trading is up 82c to $14.28. The analyst sees Sonos as the most likely company he covers to have its shares rally from either an improvement in investor perception or a takeover. Sonos is the "best house" on the "bad block" of hardware companies, and is "adjacent to the mansion on the neighboring block, Apple (AAPL)," Forte tells investors in a research note. Similar to Apple, Sonos makes products that are superior to the competition, has an eye for design, and boasts a premium brand that enables it to sell its products at higher prices than others, the analyst says. Further, Forte believes that similar to Fitbit not getting proper credit for its healthcare-related efforts, Sonos does not get credit for its superior technology and premium brand. As such, he sees Sonos as a "natural acquisition target for Apple." Furthermore, while less obvious than Apple, Amazon (AMZN) could acquire Sonos to advance its connected home efforts, according to Forte. The analyst also thinks the company could go private given the "lack of appreciation by Wall Street."
11/07/19
COWN
11/07/19
NO CHANGE
Target $100
COWN
Outperform
Qualcomm price target raised to $100 from $80 at Cowen
Cowen analyst Matthew Ramsey raised his price target on Qualcomm (QCOM) to $100 from $80 following better than expected Q4 results. The analyst cited its settlement with Apple (AAPL) and the potential for 2020/2021 5G modem/RF chips selling prices to move sharply higher and boost out-year estimates. He said shares continue to demonstrate a favorable risk/reward. Ramsey reiterated his Outperform rating on Qualcomm shares.
11/07/19
RBCM
11/07/19
NO CHANGE
Target $88
RBCM
Sector Perform
Qualcomm price target raised to $88 from $75 at RBC Capital
RBC Capital analyst Mitch Steves raised his price target on Qualcomm (QCOM) to $88 after its Q4 earnings beat and better than expected Q1 guidance, noting that its 5G unit shipment forecast of 175M-225M in 2020 implies a production ramp. The analyst still keeps his Sector Perform rating on the stock to reflect the continued FTC overhang and potential Apple (AAPL) modem chip in the future.
11/06/19
BOFA
11/06/19
NO CHANGE
Target $270
BOFA
Buy
Apple shares still have 'significant room to run,' says BofA/Merrill
BofA Merrill Lynch analyst Wamsi Mohan noted that his recent talks with investors lead him to believe there is skepticism about incremental upside in Apple shares with the stock up 63% year-to-date and the S&P up 23%. However, his analysis suggests "history favors owning Apple especially after a weak cycle" and he expects material relative outperformance heading into the 5G cycle, leaving "significant room for upside" in the shares. Mohan maintains a Buy rating and $270 price target on Apple shares.
LGF.A Lionsgate
$9.11

0.79 (9.50%)

07/24/19
GSCO
07/24/19
UPGRADE
Target $19
GSCO
Buy
Lionsgate upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Drew Borst upgraded Lionsgate (LGF.A) to Buy from Neutral while lowering his price target for the shares to $19 from $24. The shares are trading at a "trough multiple" with potential catalysts to re-rate, Borst tells investors in a research note.
08/19/19
IMPC
08/19/19
UPGRADE
Target $14
IMPC
Outperform
Lionsgate upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital analyst David Miller upgraded Lionsgate to Outperform from In-Line and raised his price target on the shares to $14 from $13 citing the 27% pullback in the stock since the end of April and his view that the "worst case scenario" for a Starz-level equity raise is priced into the stock.
07/24/19
GSCO
07/24/19
UPGRADE
Target $19
GSCO
Buy
Goldman upgrades Lionsgate to Buy on 'compelling' risk/reward after selloff
Goldman Sachs analyst Drew Borst upgraded Lionsgate (LGF.A) to Buy from Neutral while lowering his price target for the shares to $19 from $24. The shares are down 24% since the company last reported results on May 23 due to concerns about forward growth, balance sheet leverage and competitive positioning, Borst tells investors in a research note. The analyst, however, finds the stock's risk/reward "compelling" at current valuation levels. He sees four potential catalysts to re-rate the multiple higher -- upward revisions to estimates, improving subscriber growth at for Starz International streaming, balance sheet de-levering, and "M&A optionality" given the growing scarcity of scaled content libraries and production assets.
09/23/19
WELS
09/23/19
INITIATION
Target $15
WELS
Outperform
Lionsgate initiated with an Outperform at Wells Fargo
Wells Fargo analyst Steven Cahall initiated Lionsgate with an Outperform rating and $15 price target, stating that sentiment is "at an all-time low, but frankly, that's the opportunity." While he does not believe a buyer for Lionsgate or Starz will come in the near-term, he does view the company as "a very logical merger partner with other midsize studios," Cahall tells investors.
LGF.B Lionsgate
$8.58

0.73 (9.30%)

06/18/19
IMPC
06/18/19
NO CHANGE
Target $13
IMPC
In-Line
Lionsgate price target lowered to $13 from $16 at Imperial Capital
Imperial Capital analyst David Miller lowered his price target for Lionsgate Entertainment (LGF.B) to $13 from $16 and maintains an In-Line rating on the shares.
04/29/19
04/29/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lionsgate (LGF, LGF.A, LGF.B) downgraded to In-Line from Outperform at Imperial Capital with analyst David Miller citing additional promotional expenses related to the Starz international rollout. 2. Occidental Petroleum (OXY) downgraded to Hold from Buy at Jefferies with analyst Jason Gammel saying the company's hostile counter-offer for Anadarko (APC) is a "risky but perhaps necessary move against a better-capitalized bidder for a company that rejected its initial overtures." 3. CVS Health (CVS) downgraded to Neutral from Outperform at Credit Suisse with analyst A.J. Rice saying the stock faces a transitional year as it tries to drive seismic changes in healthcare. 4. Intel (INTC) downgraded to Hold from Buy at Argus with analyst Jim Kelleher citing the company's Q1 earnings miss and reduced FY19 outlook that reflected the company's Data Center Group weakness, which he calls "the linchpin of growth." 5. 3M (MMM) downgraded to Hold from Buy at Gordon Haskett with analyst John Inch downgraded saying his concerns extend beyond the company's Q1 earnings miss and steep guidance reduction. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
T AT&T
$39.37

-0.05 (-0.13%)

11/05/19
RHCO
11/05/19
NO CHANGE
Target $192
RHCO
Buy
RingCentral price target raised to $192 from $163 at SunTrust
SunTrust analyst Terry Tillman raised his price target on RingCentral (RNG) to $192 and kept his Buy rating after its "strong" Q3 results with upside in subscription and total revenue along with above-consensus EBIT margins. The analyst notes that the company saw strength "across key verticals" and within its contact center business, which all contributed to strong annualized recurring revenue growth. Tillman further expects RingCentral's partnerships with AT&T (T) and Avaya (AVYA) to be key long-term catalysts.
11/01/19
STPT
11/01/19
DOWNGRADE
STPT
Hold
AT&T downgraded to Hold from Buy at Standpoint Research
Standpoint Research analyst Ronnie Moas downgraded AT&T to Hold from Buy.
11/04/19
NOMU
11/04/19
DOWNGRADE
Target $65
NOMU
Neutral
Nomura Instinet downgrades Verizon to Neutral after AT&T price cuts
Nomura Instinet analyst Jeffrey Kvaal downgraded Verizon Communications (VZ) to Neutral from Buy with a price target of $65, down from $67. The stock closed Friday down 11c to $60.37. AT&T's (T) new price reductions, and T-Mobile's (TMUS) likely response, reduces visibility into Verizon's near-term growth trajectory, Kvaal tells investors in a research note. The analyst now has lower confidence into Verizon's long-term ability to lift pricing for 5G. While he prefers wireless over fixed over time, he moves to a Neutral stance on Verizon.
11/06/19
GUGG
11/06/19
DOWNGRADE
Target $10
GUGG
Sell
Guggenheim downgrades CenturyLink to Sell with unchanged $10 target
Guggenheim analyst Mike McCormack downgraded CenturyLink (CTL) to Sell from Neutral with an unchanged price target of $10. The stock closed Tuesday up 2c to $13.67. The shares are up 41% since late May and industry data points are not encouraging, McCormack tells investors in a research note. The analyst says both comments and results from AT&T (T) and Verizon Communications (VZ) reaffirm his negative stance on the macro environment and developing trends in Wireline. Wireline results at AT&T and Verizon showed significant weakness, McCormack points out. Margin pressures for both in Wireline cause "significant concern for pure-play" CenturyLink, adds the analyst. Further, McCormack continues to believe that CenturyLink management is not likely wedded to the dividend. He has a hard time believing that the over $1B annual payment wouldn't be more appropriately applied to the company's nearly $35B of debt.
CMCSA Comcast
$45.19

0.49 (1.10%)

11/04/19
SPHN
11/04/19
NO CHANGE
Target $8
SPHN
Equal Weight
Stephens ups WideOpenWest price target to $8, remains concerned on competition
Stephens analyst Kyle Evans said shares of WideOpenWest (WOW) have held up better than he anticipated following the distribution of 27M shares by Avista to limited partners in August and that the stock responded better than he'd expected to the company's Q3 report on Friday. Though he raised his price target on the stock to $8 from $6 after unit economics in the quarter trended positively, Evans keeps an Equal Weight rating on the shares given his concerns about leverage, uncertainty around TV economics and "formidable competition" from the likes of Comcast (CMCSA), Charter (CHTR), Cable One (CABO) and Altice USA (ATUS).
10/25/19
MSCO
10/25/19
NO CHANGE
Target $53
MSCO
Overweight
Morgan Stanley says Comcast results a reminder of 'uniquely attractive position'
Morgan Stanley analyst Benjamin Swinburne said Comcast's Q3 served as a reminder of the company's "uniquely attractive position" with rising returns on invested capital as margins improve and capital intensity falls. While video subscriber losses are increasing, broadband customer growth is accelerating and sustaining this growth is the key to continued share performance, said Swinburne. Although regulatory questions around broadband may come back into focus during the 2020 election process, he also believes the "cumulative impact of years of investment in the network and product set" should not be underestimated, Swinburne added. He keeps an Overweight rating on the stock and bumped up his price target to $53 from $51.
10/25/19
GUGG
10/25/19
NO CHANGE
Target $57
GUGG
Negative view of media assets weighing on Comcast sentiment, says Guggenheim
Guggenheim analyst Mike McCormack said Comcast reported a "solid" third quarter with Cable, NBCU, total revenue, broadband net adds and EBITDA topping his expectations. While he expects free cash flow to improve given the combination of lower capex intensity and moving past film and TV working capital headwinds, he believes "sentiment for media assets remains firmly negative," which he thinks is weighing on sentiment for Comcast. He raised his price target on the stock to $57 from $52 and keeps a Buy rating on Comcast shares.
10/16/19
10/16/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Verizon (VZ), Comcast (CMCSA), and AT&T (T) initiated with Market Perform ratings at Bernstein. 2. Inovalon (INOV) initiated with a Buy at Citi. 3. Assembly Biosciences (ASMB) initiated with a Buy at Mizuho. 4. ChromaDex (CDXC) initiated with an Outperform at Oppenheimer. 5. Axsome Therapeutics (AXSM) initiated with a Buy at Guggenheim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
CMCSK Comcast
$0.00

(0.00%)

09/19/19
RSBL
09/19/19
NO CHANGE
Target $134
RSBL
Buy
Roku pullback an 'overreaction' to Comcast's free streaming box, says Rosenblatt
Rosenblatt analyst Mark Zgutowicz said yesterday's weakness in Roku (ROKU) shares was related to news that Comcast (CMSCA) will give its Xfinity Flex streaming box to its broadband only customers for free. However, he thinks the potential impact to Roku looks modest. He thinks Roku has a significant customer acquisition advantage via smart TV sell through, noting that Roku TV sales have represented an estimated 1 of 3 smart TVs sold this year. Zgutowicz maintains a Buy rating and $134 price target on Roku shares, which are down another 1% to $128.26 in pre-market trading.
09/25/19
BNCH
09/25/19
INITIATION
Target $64
BNCH
Buy
Comcast initiated with a Buy at Benchmark
Benchmark analyst Matthew Harrigan initiated Comcast with a Buy rating and $64 price target, citing his view that the company is uniquely positioned to benefit from fixed and wireless/mobile broadband growth, direct-to-consumer alternatives to traditional TV bundles and advanced advertising. He sees the potential at Comcast for low teens annual adjusted EPS growth, assuming resumed buyback activity in 2020, Harrigan said.
07/29/19
FBCO
07/29/19
NO CHANGE
FBCO
Credit Suisse sees virtually no impact for AT&T, Verizon from Dish near-term
Following the Justice Department's settlement with T-Mobile (TMUS) and Sprint (S), Credit Suisse analyst Douglas Mitchelson notes that for Altice USA (ATUS), the settlement requires mobile virtual network operator contracts to be extended through at least 7 years post closing, which he views as a "significant positive" for Altice. For cable broadly, Dish (DISH) would represent an "intriguing option" for entry into the wireless business longer-term if CEO decided to sell the company, he contends. The analyst would expect that Comcast (CMCSA) and Charter (CHTR) would wait until the point where wireless pricing and valuations are thought to have bottomed. For AT&T (T) and Verizon (VZ), Mitchelson sees virtually no impact from Dish the next few years as the company will be just focused on scaling marketing of its T-Mobile MVNO while building its wireless network. Longer-term, while Dish might be in a position to deflate wireless pricing, AT&T and Verizon should still have superior coverage, network density, backhaul, scale, and quality of service, he adds.
08/14/19
MACQ
08/14/19
DOWNGRADE
Target $31
MACQ
Neutral
Viacom downgraded to Neutral from Outperform at Macquarie
Macquarie analyst Tim Nollen downgraded Viacom (VIAB) to Neutral from Outperform and keeps a Neutral rating on CBS (CBS) shares after the two companies announced a merger deal with no premium for Viacom following "3 years of on again/off again merger discussions amidst wrenching change in the industry." While he believes the deal's strategic positives outweigh the risks, Nollen said integration might not be easy and that ViacomCBS will still be "small-ish" compared with competitors Comcast (CMCSA) and Disney (DIS). He lowered his price target on Viacom shares to $31 from $37 and cut his price target on CBS shares to $53 from $55.
HON Honeywell
$181.21

1.54 (0.86%)

07/22/19
ARGS
07/22/19
NO CHANGE
Target $195
ARGS
Buy
Momentum of Honeywell's stock price and earnings to continue, says Argus
Argus analyst John Eade keeps his Buy rating and $195 price target on Honeywell, saying that while the stock has already outperformed the S&P 500 with a 23% run over the past year, he expects that momentum to continue as the company generates low double-digit earnings growth over the next 5 years. The analyst believes that Honeywell stands to benefit from its diverse product lines, its strong presence in the commercial aerospace and commercial construction markets, as well as its "mid-market" product presence in China that is growing in spite of the country's infrastructure slowdown.
09/23/19
GSCO
09/23/19
DOWNGRADE
Target $144
GSCO
Sell
Illinois Tool Works downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Joe Ritchie downgraded Illinois Tool Works (ITW) to Sell from Neutral and lowered his price target for the shares to $144 from $147. Given the company's "deteriorating fundamentals," there is downside risk to consensus estimates and its valuation premium relative to Large Cap Defensive peers "appears too high," Ritchie tells investors in a research note. The analyst believes growth in all of Illinois Tool Works' segments could turn negative in Q4 while the return to greater than 2% growth in 2020 "could prove optimistic." Further, after years of transforming the cost structure and driving meaningful margin expansion, the company "has less levers to pull to expand margins," says Ritchie. The analyst continues to view Honeywell (HON) as the best Large Cap Defensive to own.
07/19/19
JEFF
07/19/19
NO CHANGE
Target $195
JEFF
Buy
Honeywell price target raised to $195 from $190 at Jefferies
Jefferies analyst Sheila Kahyaoglu raised her price target for Honeywell to $195 from $190 saying the company delivered 5% organic growth in Q2 with segment profit expanding 9% organically. The analyst raised her out-year estimates on better profitability within Aerospace and keeps a Buy rating on the shares.
07/16/19
GSCO
07/16/19
NO CHANGE
GSCO
Goldman does not see favorable setup for Americas Multi-Industry into Q2
Goldman Sachs analyst Joe Ritchie does not see the setup as favorable for the Americas Multi-Industry sector into the Q2 reporting season with the exception of Buy-rated Honeywell (HON). The analyst says fiscal 2020 consensus expectations are too high for a third of the companies he covers while the setup is tough for the second half of 2019 as comps are only easier for five out of 27 stocks "at a time when growth is decelerating." As a result, Ritchie downgraded three cyclical stocks to Sell, namely Cognex (CGNX) and Parker-Hannifin (PH) from Neutral and Kennametal (KMT) double downgraded from Buy. He also upgraded Timken to Buy from Neutral as he believes expectations are more appropriately calibrated and its relative valuation is "compelling."
OSK Oshkosh
$90.00

1.19 (1.34%)

10/31/19
LBOW
10/31/19
DOWNGRADE
LBOW
Neutral
Oshkosh downgraded to Neutral from Buy at Longbow
Longbow analyst Christopher Olin downgraded Oshkosh to Neutral from Buy.
10/31/19
RBCM
10/31/19
NO CHANGE
Target $98
RBCM
Oshkosh price target raised to $98 from $92 at RBC Capital
RBC Capital analyst Seth Weber raised his price target on Oshkosh to $98 and kept his Outperform rating after the company beat expectations across most of its segments in Q4. The analyst further cites a "better than feared Access decremental margin" as a "notable positive" and sees the stock as "inexpensive" based on the ramping Defense business at Oshkosh.
11/08/19
GSCO
11/08/19
UPGRADE
Target $90
GSCO
Neutral
Oshkosh upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Jerry Revich upgraded Oshkosh to Neutral from Sell with a price target of $90, up from $66. The analyst believes the company is well positioned to benefit from the production cycle recovery in the second half of 2020. Further, Oshkosh's Defense business outlook remains solid and its Fire & Emergency segment has scope for further margin improvement, Revich tells investors in a research note.
10/31/19
LBOW
10/31/19
DOWNGRADE
LBOW
Neutral
Oshkosh downgraded to Neutral on valuation at Longbow
Longbow analyst Christopher Olin downgraded Oshkosh to Neutral from Buy after the stock hit the analyst's prior price target of $89. Olin says his optimism in the company's Defense segment is now equally matched by questions around the sustainability of its Access Equipment and Commercial unit. He believes his valuation call played out and has less conviction around the future catalysts.
UBER Uber
$27.01

-0.33 (-1.21%)

11/05/19
OPCO
11/05/19
NO CHANGE
Target $45
OPCO
Outperform
Uber price target lowered to $45 from $55 at Oppenheimer
Oppenheimer analyst Jason Helfstein lowered his price target for Uber to $45 from $55, citing a decline in peer multiples and a more competitive food delivery environment, but maintains an Outperform rating as Rides economics are improving and management expects EBITDA break-even in 2021 vs. his prior 2022 assumption.
11/07/19
BOFA
11/07/19
NO CHANGE
Target $44
BOFA
Buy
Uber trading at discount to peers amid lock-up pressure, says BofA/Merrill
BofA Merrill Lynch analyst Justin Post noted that 134M shares of Uber stock traded yesterday, which compares to average daily volume of about 12M shares since its IPO and represents around 9% of the 1.4B shares unlocked by the expiration of the IPO lock-up provisions. The stock's roughly 4% decline was consistent with the recent basket of Internet IPOs he compares it to, which declined 2.3% on average on the day of lock-up expiration, Post added. He thinks lock-up related selling will likely remain a headwind in November, but he also notes that the company's current adjusted market cap of $30.4B implies a valuation discount to GrubHub (GRUB) and Lyft (LYFT). The analyst, who sees support coming from new segment disclosures and sum-of-the-parts valuation despite the lock-up overhang, keeps a Buy rating on Uber shares with a $44 price target.
11/05/19
DADA
11/05/19
NO CHANGE
Target $35
DADA
Neutral
Uber price target lowered to $35 from $44 at DA Davidson
DA Davidson analyst Tom White lowered his price target on Uber to $35 and kept his Neutral rating after its Q3 results. The analyst says the quarter was "solid but somewhat mixed", with Gross Bookings, monthly active platform consumers, and trips all a bit light of consensus and revenue/EBITDA loss metrics "generally better". White boosts his 2020 EBITDA estimate by $1.29B to ($1.17B), but lowers his assumed enterprise value to expected 2020 sales multiple to 3.3-times from 4.1-times.
11/05/19
MSCO
11/05/19
NO CHANGE
Target $55
MSCO
Overweight
After Uber earnings, Morgan Stanley sees four reasons to be bullish in 2020
After Uber reported Q3 results and gave new segment disclosures, Morgan Stanley analyst Brian Nowak highlighted four reasons he sees to be bullish. Namely, the company is targeting being breakeven for 2021, which is a year earlier than expected; Rides segment bookings and adjusted net revenue were 1% and 5%, respectively, better than expected; ...Eats segment bookings were 4% lighter than he expected, but its adjusted EBITDA losses were 10% below what he forecast; and messaging about the future of online food delivery industry was "more rational," according to Nowak. Following the quarterly report, Nowak raised his 20/21 EBITDA estimates, increased his price target on Uber shares to $55 from $53 and suggested the shares be bought on weakness through the upcoming lock-up period. Nowak keeps an Overweight rating on Uber shares.

TODAY'S FREE FLY STORIES

WFC

Wells Fargo

$53.80

0.3 (0.56%)

, AAPL

Apple

$265.73

3.07 (1.17%)

10:01
11/16/19
11/16
10:01
11/16/19
10:01
Periodicals
Berkshire Hathaway inactive with record cash hoard, Barron's says »

Berkshire Hathaway…

WFC

Wells Fargo

$53.80

0.3 (0.56%)

AAPL

Apple

$265.73

3.07 (1.17%)

OXY

Occidental Petroleum

$38.94

1.18 (3.13%)

BRK.B

Berkshire Hathaway

$219.74

0.38 (0.17%)

BRK.A

Berkshire Hathaway

$329,361.11

266.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

DIS

Disney

$144.63

-2.56 (-1.74%)

09:43
11/16/19
11/16
09:43
11/16/19
09:43
Periodicals
Disney+ may not be able to hold onto huge number of subs, Barron's says »

While Disney's (DIS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$112.11

2.9 (2.66%)

09:27
11/16/19
11/16
09:27
11/16/19
09:27
Periodicals
Medtronic shares 'could rise even more,' Barron's says »

Barron's recommended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BR

Broadridge

$119.80

0.485 (0.41%)

09:18
11/16/19
11/16
09:18
11/16/19
09:18
Periodicals
Broadridge a defensive name that can withstand slowdown, Barron's says »

Broadridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$193.95

-0.02 (-0.01%)

, MDT

Medtronic

$112.11

2.9 (2.66%)

09:07
11/16/19
11/16
09:07
11/16/19
09:07
Periodicals
Barron's suggests dividend stocks for retirement savers »

In this week's…

MCD

McDonald's

$193.95

-0.02 (-0.01%)

MDT

Medtronic

$112.11

2.9 (2.66%)

KO

Coca-Cola

$52.67

0.03 (0.06%)

PRU

Prudential

$93.61

0.82 (0.88%)

SYF

Synchrony

$37.05

0.34 (0.93%)

KEY

KeyCorp

$18.96

0.1 (0.53%)

T

AT&T

$39.49

0.53 (1.36%)

AMGN

Amgen

$220.84

2.29 (1.05%)

CSCO

Cisco

$45.10

0.18 (0.40%)

RCL

Royal Caribbean

$117.91

2.69 (2.33%)

MRK

Merck

$84.89

0.33 (0.39%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

JPM

JPMorgan

$129.51

0.83 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 02

    Dec

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 14

    Jan

  • 21

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 14

    Mar

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

, MSFT

Microsoft

$149.95

1.89 (1.28%)

08:54
11/16/19
11/16
08:54
11/16/19
08:54
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

AAPL

Apple

$265.73

3.07 (1.17%)

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

THC

Tenet

$30.55

1.08 (3.66%)

GM

General Motors

$36.87

0.07 (0.19%)

FCAU

Fiat Chrysler

$16.02

0.04 (0.25%)

TM

Toyota

$144.29

1.16 (0.81%)

F

Ford

$8.96

0.16 (1.82%)

HMC

Honda

$28.99

0.155 (0.54%)

VWAGY

Volkswagen

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 04

    Feb

  • 06

    Feb

MDCO

The Medicines Co.

$51.92

1.03 (2.02%)

04:55
11/16/19
11/16
04:55
11/16/19
04:55
Conference/Events
Roth Capital pharmaceuticals analysts to hold a luncheon »

Analysts host Dr. John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

CVET

Covetrus

$14.93

1.44 (10.67%)

18:41
11/15/19
11/15
18:41
11/15/19
18:41
Hot Stocks
Covetrus CEO: We're a leader in the humanization of pets »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.54

-0.93 (-2.05%)

18:02
11/15/19
11/15
18:02
11/15/19
18:02
Hot Stocks
Viacom extends cable deal for 'The Office' through 2025 »

Viacom (VIA) announced…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.54

-0.93 (-2.05%)

VIAB

Viacom

$23.07

0.59 (2.62%)

VIA

Viacom

$26.59

1.28 (5.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CWK

Cushman & Wakefield

$19.10

0.1 (0.53%)

17:48
11/15/19
11/15
17:48
11/15/19
17:48
Hot Stocks
Cushman & Wakefield CEO sells 84.6K share of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LMT

Lockheed Martin

$393.52

3.305 (0.85%)

17:39
11/15/19
11/15
17:39
11/15/19
17:39
Hot Stocks
Lockheed Martin awarded maximum $3.33B Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESCA

Escalade

$10.90

-0.09 (-0.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Escalade CEO Fetherman to retire »

Escalade announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.96

0.1 (0.78%)

, ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Eldorado, Caesars stockholders approve Eldorado acquisition of Caesars »

Eldorado Resorts (ERI)…

CZR

Caesars

$12.96

0.1 (0.78%)

ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EGRX

Eagle Pharmaceuticals

$57.24

0.55 (0.97%)

17:15
11/15/19
11/15
17:15
11/15/19
17:15
Syndicate
Breaking Syndicate news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

$60.82

0.84 (1.40%)

17:11
11/15/19
11/15
17:11
11/15/19
17:11
Hot Stocks
Fabrinet President Gill sells 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEUM

Pareteum

$0.38

-0.0209 (-5.21%)

17:05
11/15/19
11/15
17:05
11/15/19
17:05
Hot Stocks
Pareteum receives noncompliance notice from Nasdaq »

Pareteum announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

Hexo

$1.78

-0.1 (-5.32%)

17:00
11/15/19
11/15
17:00
11/15/19
17:00
Hot Stocks
Hexo was cannabis was being grown in unlicensed space at Niagara site »

HEXO Corp provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$220.84

2.29 (1.05%)

, CELG

Celgene

$110.02

-0.01 (-0.01%)

16:57
11/15/19
11/15
16:57
11/15/19
16:57
Hot Stocks
Bristol-Myers gets FTC clearance for Celgene acquisition »

Bristol-Myers Squibb…

AMGN

Amgen

$220.84

2.29 (1.05%)

CELG

Celgene

$110.02

-0.01 (-0.01%)

BMY

Bristol-Myers

$58.61

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

RAVE

Rave Restaurant

$1.44

-0.79 (-35.43%)

16:47
11/15/19
11/15
16:47
11/15/19
16:47
Hot Stocks
BBRC Asset Management reports 6.6% passive stake in Rave Restaurant »

BBRC Asset Management …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHAP

Chaparral Energy

$0.89

-0.0521 (-5.52%)

16:46
11/15/19
11/15
16:46
11/15/19
16:46
Hot Stocks
Chaparral Energy receives continued listing standard notice from NYSE »

Chaparral Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

CI

Cigna

$196.08

6.41 (3.38%)

, CNC

Centene

$57.57

2.91 (5.32%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks closed out the…

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

NVDA

Nvidia

$204.12

-5.76 (-2.74%)

AMZN

Amazon.com

$1,739.33

-15.38 (-0.88%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

UAA

Under Armour

$17.78

0.65 (3.79%)

UA

Under Armour

$15.97

0.41 (2.64%)

AMRN

Amarin

$23.99

2.5 (11.63%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

GOOG

Alphabet

$1,334.01

21.82 (1.66%)

GOOGL

Alphabet Class A

$1,333.33

23.54 (1.80%)

ORCL

Oracle

$56.43

0.33 (0.59%)

RH

RH

$188.73

13.535 (7.73%)

QGEN

Qiagen

$40.56

3.255 (8.73%)

FTCH

Farfetch

$9.66

2.17 (28.97%)

THC

Tenet

$30.55

1.08 (3.66%)

TORC

resTORbio

$1.10

-6.83 (-86.13%)

ACB

Aurora Cannabis

$2.72

-0.57 (-17.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 28

    Dec

  • 06

    Jan

  • 21

    Jan

  • 06

    Feb

NYT

New York Times

$31.60

0.44 (1.41%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
New York Times CEO sells 66,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WEX

Wex

$200.52

4.61 (2.35%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
Wex director Morris sells 3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.